:: Library Catalog

Buchumschlag

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Binqi Li, Zizhong Yang, Yang Liu, Xin Zhou, Weiqing Wang, Zhengnan Gao, Li Yan, Guijun Qin, Xulei Tang, Qin Wan, Lulu Chen, Zuojie Luo, Guang Ning, Weijun Gu, Yiming Mu
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Journal of Diabetes
Online-Zugang:	https://onlinelibrary.wiley.com/doi/10.1111/1753-0407.13596
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Remnant cholesterol is more positively related to diabetes, prediabetes, and insulin resistance than conventional lipid parameters and lipid ratios: A multicenter, large sample survey
von: Binqi Li, et al.
Veröffentlicht: (2024)

Remnant cholesterol, but not other traditional lipids or lipid ratios, is independently and positively related to future diabetes risk in Chinese general population: A 3 year cohort study
von: Binqi Li, et al.
Veröffentlicht: (2024)

Development and validation of a machine learning‐based model to predict isolated post‐challenge hyperglycemia in middle‐aged and elder adults: Analysis from a multicentric study
von: Rui Hou, et al.
Veröffentlicht: (2024)

Association of body roundness index with cardiovascular disease and all‐cause mortality among Chinese adults
von: Hong Lin, et al.
Veröffentlicht: (2025)

Association between weight‐adjusted‐waist index and incident carotid atherosclerosis in the general adult population in Chinese communities: Evidence from the REACTION cohort study
von: Qingzheng Wu, et al.
Veröffentlicht: (2025)

Association of advanced glycation end products with ear lobe crease: A cross‐sectional study
von: Yuepeng Wang, et al.
Veröffentlicht: (2024)

Association Between Socioeconomic Status and the Prevalence of Metabolic Diseases: A Nationwide Cross‐Sectional Study in China
von: Minghan Zhang, et al.
Veröffentlicht: (2026)

Body size, insulin sensitivity, metabolic health and risk of cardiovascular disease in Chinese adults: Insights from the China Cardiometabolic Disease and Cancer Cohort (4C) study
von: Chunyan Hu, et al.
Veröffentlicht: (2024)

Efficacy and safety of iGlarLixi versus IDegAsp by baseline β‐cell function in Chinese people with type 2 diabetes: Exploratory analyses of the Soli‐D study
von: Weijun Gu, et al.
Veröffentlicht: (2025)

The causal relationship between plasma protein‐to‐protein ratios and type 2 diabetes and its complications: Proteomics mendelian randomization study
von: Yue‐Yang Zhang, et al.
Veröffentlicht: (2024)

The efficacy and safety of iGlarLixi versus IDegAsp in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli‐D randomized controlled trial
von: Ming Liu, et al.
Veröffentlicht: (2024)

Front Cover
von: Hong Lin, et al.
Veröffentlicht: (2025)

Identification of subtypes of type 2 diabetes in the Chinese population and their distinct complication risk profiles
von: Qiu Xiao, et al.
Veröffentlicht: (2025)

Front Cover
von: Chunyan Hu, et al.
Veröffentlicht: (2024)

The efficacy and safety of insulin glargine 100 U/mL + lixisenatide versus insulin degludec + insulin aspart in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli‐D randomized controlled trial
von: Yiming Mu
Veröffentlicht: (2024)

Protective effects of 23‐valent pneumococcal polysaccharide vaccination against mortality among elder patients with type 2 diabetes mellitus
von: Xiaoling Peng, et al.
Veröffentlicht: (2026)

Development and validation of a prediction model for self‐reported hypoglycemia risk in patients with type 2 diabetes: A longitudinal cohort study
von: Hongmei Xu, et al.
Veröffentlicht: (2024)

Effects of SGLT2 inhibitors on development and progression of kidney disease in Chinese patients with type 2 diabetes: A multicentre, prospective real‐world study
von: Yun Wang, et al.
Veröffentlicht: (2025)

The role of vascular adhesion protein‐1 in diabetes and diabetic complications
von: I‐Weng Yen, et al.
Veröffentlicht: (2024)

Clinical metabolomics characteristics of diabetic kidney disease: A meta‐analysis of 1875 cases with diabetic kidney disease and 4503 controls
von: Yu Yuan, et al.
Veröffentlicht: (2024)

Cofrogliptin once every 2 weeks as add‐on therapy to metformin versus daily linagliptin in patients with type 2 diabetes in China: A randomized, double‐blind, non‐inferiority trial
von: Qian Ren, et al.
Veröffentlicht: (2024)

Pathophysiology of type 2 diabetes: A focus on the metabolic differences among southeast Asian, Chinese and Indian populations and how this impacts treatment
von: Yuzi Cao, et al.
Veröffentlicht: (2025)

Comparison of ultrasound scanning and clinical examination for detecting insulin injection related Lipohypertrophy and construction of Lipohypertrophy classification table
von: Hongmei Xu, et al.
Veröffentlicht: (2024)

Trajectories of body mass index and diabetes mellitus risk among elderly Chinese adults: A 10‐year longitudinal study
von: Yan Guo, et al.
Veröffentlicht: (2025)

Evaluating the incidence of complications among people with diabetes according to age of onset: Findings from the UK Biobank
von: Seyedeh Forough Sajjadi, et al.
Veröffentlicht: (2024)

Association Between Skin Autofluorescence and Coronary Heart Disease in Chinese General Population: A Cross‐Sectional Study
von: Qingzheng Wu, et al.
Veröffentlicht: (2025)

Early Glycemic Control With iGlarLixi Versus IDegAsp in Chinese Adults With Type 2 Diabetes: A Post Hoc Analysis of the Soli‐D Study
von: Xiaohong Wu, et al.
Veröffentlicht: (2025)

Amino acid metabolism modulates chronic kidney disease progression by mediating the aging process: Mechanistic insights and therapeutic interventions
von: Yi Song, et al.
Veröffentlicht: (2026)

The exosome‐ PI3K /Akt‐autophagy axis in diabetic vascular complications: Mechanisms and implications
von: Wei Liu, et al.
Veröffentlicht: (2025)

Real‐world glycaemic outcomes of automated insulin delivery in type 1 diabetes: A meta‐analysis
von: Qin Yang, et al.
Veröffentlicht: (2024)

Effectiveness of finerenone in Chinese patients with type 2 diabetes mellitus and chronic kidney disease with microalbuminuria: A retrospective real‐world study
von: Yiming Wu, et al.
Veröffentlicht: (2025)

Real‐world treatment satisfaction with dulaglutide, and its influencing factors, in a Chinese population with type 2 diabetes mellitus
von: Lixin Guo, et al.
Veröffentlicht: (2024)

Gestational diabetes risk associated with early pregnancy blood pressure characteristics and trajectories: A Chinese prospective cohort study
von: Weigui Ni, et al.
Veröffentlicht: (2025)

Associations of body mass index trajectory, waist circumference trajectory, or both with type 2 diabetes mellitus risk in Chinese adults: The China‐PAR project
von: Yang Zhao, et al.
Veröffentlicht: (2024)

Safety and efficacy of hybrid closed‐loop insulin pump therapy in adolescents and adults with type 1 diabetes in China
von: Jing Shen, et al.
Veröffentlicht: (2025)

Efficacy and safety of once‐weekly semaglutide 2.4 mg for weight management in participants from China: A prespecified analysis of the STEP 7 randomized clinical trial
von: Weijun Gu, et al.
Veröffentlicht: (2025)

Association between two novel anthropometric measures and type 2 diabetes in a Chinese population
von: Di Wang, et al.
Veröffentlicht: (2024)

The interaction effect between BMI , diabetes and age at diabetes onset on the risk of thyroid cancer: A population‐based cohort study in Shanghai, China
von: Tianzhichao Hou, et al.
Veröffentlicht: (2024)

Visit‐to‐visit HbA1c variability, risk of all‐cause mortality and diabetes‐related vascular complications among adult individuals with type 2 diabetes mellitus
von: Moses Yidong Lim, et al.
Veröffentlicht: (2026)

Diagnosis and treatment of diabetic foot ulcer complicated with lower extremity vasculopathy: Consensus recommendation from the Chinese Medical Association (CMA), Chinese Medical Doctor Association (CMDA)
von: Kejia Wang, et al.
Veröffentlicht: (2024)